Zurich Cantonal Bank
RYTM icon

Zurich Cantonal Bank’s Rhythm Pharmaceuticals RYTM Stock Holding History

Zurich Cantonal Bank’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,435
Closed -$1.33M – 3350
2025
Q4 		$1.33M Buy
+12,435
New +$1.32M ﹤0.01% 1183

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Zurich Cantonal Bank's RYTM Position: Q2 2026 in Review

Zurich Cantonal Bank increased its Rhythm Pharmaceuticals (RYTM) stake by 48% in Q2 2026, buying an estimated $679K and bringing the position to 23,109 shares worth $2.57M. The position accounts for ﹤0.01% of the portfolio, ranked #993.

Zurich Cantonal Bank first reported a position in RYTM in Q4 2019 and has held it in 26 quarters since. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Zurich Cantonal Bank held 23,109 shares of Rhythm Pharmaceuticals worth $2.57M as of Q2 2026.
  • Zurich Cantonal Bank bought 7,511 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $679K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #993 holding.
  • Zurich Cantonal Bank first reported a position in Rhythm Pharmaceuticals in Q4 2019 and has held it in 26 quarters since.
  • 304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.